Le Calvez-Kelm Florence
Количество цитирований статей в журналах по данным
Web of Science: 391,
Scopus: 382
IstinaResearcherID (IRID): 321050366
Деятельность
-
Статьи в журналах
-
-
2021
Sexual dimorphism in cancer: insights from transcriptional signatures in kidney tissue and renal cell carcinoma
-
Laskar R.S.,
Li P,
Ecsedi S.,
Abedi-Ardekani B.,
Durand G.,
Robinot N.,
Hubert J.N.,
Janout V.,
Zaridze D.,
Mukeria A.,
Mates D.,
Holcatova I.,
Foretova L.,
Swiatkowska B.,
Dzamic Z.,
Milosavljevic S.,
Olaso R.,
Boland A.,
Deleuze J.F.,
Muller D.C.,
McKay J.D.,
Brennan P.,
Le Calvez-Kelm F.,
Scelo G.,
Chanudet E.
-
в журнале Human Molecular Genetics, издательство Oxford University Press (United Kingdom), том 30, № 5, с. 343-355
-
-
2020
Circulating tumour-derived KRAS mutations in pancreatic cancer cases are predominantly carried by very short fragments of cell-free DNA
-
Zvereva Maria,
Roberti Gabriel,
Durand Geoffroy,
Voegele Catherine,
Nguyen Minh Dao,
Delhomme Tiffany M.,
Chopard Priscilia,
Fabianova Eleonora,
Adamcakova Zora,
Holcatova Ivana,
Foretova Lenka,
Janout Vladimir,
Brennan Paul,
Foll Matthieu,
Byrnes Graham B.,
McKay James D.,
Scelo Ghislaine,
Le Calvez-Kelm Florence
-
в журнале EBIOMEDICINE, том 55
DOI
-
-
2019
Sex specific associations in genome wide association analysis of renal cell carcinoma
-
Laskar R.S.,
Muller D.C.,
Li P,
Machiela M.J.,
Ye Y.,
Gaborieau V.,
Foll M.,
Hofmann J.N.,
Colli L.,
Sampson J.N.,
Wang Z.,
Bacq-Daian D.,
Boland A.,
Abedi-Ardekani B.,
Durand G.,
Le Calvez-Kelm F.,
Robinot N.,
Blanche H.,
Prokhortchouk E.,
Skryabin K.G.,
Burdett L.,
Yeager M.,
Radojevic-Skodric S.,
Savic S.,
Foretova L.,
Holcatova I.,
Janout V.,
Mates D.,
Rascu S.,
Mukeria A.,
Zaridze D.,
Bencko V.,
Cybulski C.,
Fabianova E.,
Jinga V.,
Lissowska J.,
Lubinski J.,
Navratilova M.,
Rudnai P.,
Świątkowska B.,
Benhamou S.,
Cancel-Tassin G.,
Cussenot O.,
Trichopoulou A.,
Riboli E.,
Overvad K.,
Panico S.,
Ljungberg B.,
Sitaram R.T.,
Giles G.G.,
Milne R.L.,
Severi G.,
Bruinsma F.,
Fletcher T.,
Koppova K.,
Larsson S.C.,
Wolk A.,
Banks R.E.,
Selby P.J.,
Easton D.F.,
Pharoah P.,
Andreotti G.,
Beane Freeman L.E.,
Koutros S.,
Albanes D.,
Männistö S.,
Weinstein S.,
Clark P.E.,
Edwards T.L.,
Lipworth L.,
Carol H.,
Freedman M.L.,
Pomerantz M.M.,
Cho E.,
Kraft P.,
Preston M.A.,
Wilson K.M.,
Michael Gaziano J.,
Sesso H.D.,
Black A.,
Freedman N.D.,
Huang W.Y.,
Anema J.G.,
Kahnoski R.J.,
Lane B.R.,
Noyes S.L.,
Petillo D.,
Teh B.T.,
Peters U.,
White E.,
Anderson G.L.,
Johnson L.,
Luo J.,
Chow W.H.,
Moore L.E.,
Choueiri T.K.,
Wood C.,
Johansson M.,
McKay J.D.,
Brown K.M.,
Rothman N.,
Lathrop M.G.,
Deleuze J.F.,
Wu X.,
Brennan P.,
Chanock S.J.,
Purdue M.P.,
Scelo G.
-
в журнале European Journal of Human Genetics, издательство Nature Publishing Group (United Kingdom), том 27, № 10, с. 1589-1598
-
-
2017
Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer
-
Wang Y.,
McKay J.D.,
Rafnar T.,
Wang Z.,
Timofeeva M.N.,
Broderick P.,
Zong X.,
Laplana M.,
Wei Y.,
Han Y.,
Lloyd A.,
Delahaye-Sourdeix M.,
Chubb D.,
Gaborieau V.,
Wheeler W.,
Chatterjee N.,
Thorleifsson G.,
Sulem P.,
Liu G.,
Kaaks R.,
Henrion M.,
Kinnersley B.,
Vallée M.,
Le Calvez-Kelm F.,
Stevens V.L.,
Gapstur S.M.,
Chen W.V.,
Zaridze D.,
Szeszenia-Dabrowska N.,
Lissowska J.,
Rudnai P.,
Fabianova E.,
Mates D.,
Bencko V.,
Foretova L.,
Janout V.,
Krokan H.E.,
Gabrielsen M.E.,
Skorpen F.,
Vatten L.,
Njølstad I.,
Chen C.,
Goodman G.,
Benhamou S.,
Vooder T.,
Välk K.,
Nelis M.,
Metspalu A.,
Lener M.,
Lubiński J.,
Johansson M.,
Vineis P.,
Agudo A.,
Clavel-Chapelon F.,
Bueno-de-Mesquita H.B.,
Trichopoulos D.,
Khaw K.T.,
Johansson M.,
Weiderpass E.,
Tjønneland A.,
Riboli E.,
Lathrop M.,
Scelo G.,
Albanes D.,
Caporaso N.E.,
Ye Y.,
Gu J.,
Wu X.,
Spitz M.R.,
Dienemann H.,
Rosenberger A.,
Su L.,
Matakidou A.,
Eisen T.,
Stefansson K.,
Risch A.,
Chanock S.J.,
Christiani D.C.,
Hung R.J.,
Brennan P.,
Landi M.T.,
Houlston R.S.,
Amos C.I.
-
в журнале Nature Genetics, издательство Nature Publishing Group (United Kingdom), том 49, № 4, с. 651
-
-
2016
Elucidating Genomic Characteristics of Lung Cancer Progression from In Situ to Invasive Adenocarcinoma
-
Vinayanuwattikun C.,
Le Calvez-Kelm F.,
Abedi-Ardekani B.,
Zaridze D.,
Mukeria A.,
Voegele C.,
Vallée M.,
Purnomosari D.,
Forey N.,
Durand G.,
Byrnes G.,
Mckay J.,
Brennan P.,
Scelo G.
-
в журнале Scientific reports, издательство Nature Publishing Group (United Kingdom), том 6, с. 1-10
-
-
2016
Identification of Circulating Tumor DNA for the Early Detection of Small-cell Lung Cancer
-
Fernandez-Cuesta L.,
Perdomo S.,
Avogbe P.H.,
Leblay N.,
Delhomme T.M.,
Gaborieau V.,
Abedi-Ardekani B.,
Chanudet E.,
Olivier M.,
Zaridze D.,
Mukeria A.,
Vilensky M.,
Holcatova I.,
Polesel J.,
Simonato L.,
Canova C.,
Lagiou P.,
Brambilla C.,
Brambilla E.,
Byrnes G.,
Scelo G.,
Le Calvez-Kelm F.,
Foll M.,
McKay J.D.,
Brennan P.
-
в журнале EBIOMEDICINE, том 10, с. 117-123
-
-
2014
Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer
-
Wang Y.,
McKay J.D.,
Rafnar T.,
Wang Z.,
Timofeeva M.N.,
Broderick P.,
Zong X.,
Laplana M.,
Wei Y.,
Han Y.,
Lloyd A.,
Delahaye-Sourdeix M.,
Chubb D.,
Gaborieau V.,
Wheeler W.,
Chatterjee N.,
Thorleifsson G.,
Sulem P.,
Liu G.,
Kaaks R.,
Henrion M.,
Kinnersley B.,
Vallée M.,
LeCalvez-Kelm F.,
Stevens V.L.,
Gapstur S.M.,
Chen W.V.,
Zaridze D.,
Szeszenia-Dabrowska N.,
Lissowska J.,
Rudnai P.,
Fabianova E.,
Mates D.,
Bencko V.,
Foretova L.,
Janout V.,
Krokan H.E.,
Gabrielsen M.E.,
Skorpen F.,
Vatten L.,
Njølstad I.,
Chen C.,
Goodman G.,
Benhamou S.,
Vooder T.,
Välk K.,
Nelis M.,
Metspalu A.,
Lener M.,
Lubiński J.,
Johansson M.,
Vineis P.,
Agudo A.,
Clavel-Chapelon F.,
Bueno-de-Mesquita H.B.,
Trichopoulos D.,
Khaw K.T.,
Johansson M.,
Weiderpass E.,
Tjønneland A.,
Riboli E.,
Lathrop M.,
Scelo G.,
Albanes D.,
Caporaso N.E.,
Ye Y.,
Gu J.,
Wu X.,
Spitz M.R.,
Dienemann H.,
Rosenberger A.,
Su L.,
Matakidou A.,
Eisen T.,
Stefansson K.,
Risch A.,
Chanock S.J.,
Christiani D.C.,
Hung R.J.,
Brennan P.,
Landi M.T.,
Houlston R.S.,
Amos C.I.
-
в журнале Nature Genetics, издательство Nature Publishing Group (United Kingdom), том 46, № 7, с. 736-741
DOI
-
-
2010
TP53, EGFR, and KRAS mutations in relation to VHL inactivation and lifestyle risk factors in renal-cell carcinoma from central and eastern Europe
-
Szymańska K.,
Moore L.E.,
Rothman N.,
Chow W.H.,
Waldman F.,
Jaeger E.,
Waterboer T.,
Foretova L.,
Navratilova M.,
Janout V.,
Kollarova H.,
Zaridze D.,
Matveev V.,
Mates D.,
Szeszenia-Dabrowska N.,
Holcatova I.,
Bencko V.,
Le Calvez-Kelm F.,
Villar S.,
Pawlita M.,
Boffetta P.,
Hainaut P.,
Brennan P.
-
в журнале Cancer Letters, издательство Elsevier BV (Netherlands), том 293, № 1, с. 92-98